Product Information
CIPROFLOXACIN HCL 750 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2502 per EA under NDC 00143992950. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 9, 2004.
Strength
750 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143992950
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076558FDA Approved
6/9/2004
On Market Since
6/9/2004
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 750 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2502 per EA |
|---|---|
| All-time high | $0.3928 (Feb 10, 2016) |
| All-time low | $0.1714 (Nov 21, 2018) |
| 52-week high | $0.2688 |
| 52-week low | $0.2433 |
| Median price | $0.2632 |
| Average price | $0.2683 |
| Largest weekly change | +60.8% (Feb 23, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciprofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 750 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 750 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2502 per EA (NDC 00143992950), effective Sep 30, 2026.
How has the price of CIPROFLOXACIN HCL 750 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 750 MG TAB has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 750 MG TAB?
Since Nov 28, 2013, the NADAC for CIPROFLOXACIN HCL 750 MG TAB has ranged from a low of $0.1714 (Nov 21, 2018) to a high of $0.3928 (Feb 10, 2016), with a median of $0.2632 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 750 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CIPROFLOXACIN HCL 750 MG TAB, is $0.2458 per EA — about 2% below CIPROFLOXACIN HCL 750 MG TAB.
Who manufactures CIPROFLOXACIN HCL 750 MG TAB?
CIPROFLOXACIN HCL 750 MG TAB (NDC 00143992950) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.